PHASE-I TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, EPIRUBICIN AND 5-FLUOROURACIL (CEF) FOR STAGE-II BREAST-CANCER

被引：0
|
作者：
JONES, SE
MENNEL, RG
PETERS, GN
WESTRICK, MA
BROOKS, BD
KNOX, SM
MCGUFFEY, P
机构：
来源：
INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 198
页数：4
相关论文
共 50 条
  • [41] ANALYSIS OF DOSE INTENSITY FOR ADJUVANT CHEMOTHERAPY TRIALS IN STAGE-II BREAST-CANCER
    HRYNIUK, W
    LEVINE, MN
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (08) : 1162 - 1170
  • [42] Phase I/II trial of adjuvant dose-dense docetaxel/epirubicin/cyclophosphamide (TEC) in stage II and III breast cancer
    Burdette-Radoux, Susan
    Wood, Marie E.
    Olin, Julie J.
    Laughlin, Rebecca S.
    Crocker, Abigail M.
    Ashikaga, Takamaru
    Muss, Hyman B.
    BREAST JOURNAL, 2007, 13 (03): : 274 - 280
  • [43] 5-FLUOROURACIL, ADRIAMYCIN AND CYCLOPHOSPHAMIDE (FAC) COMBINATION CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
    BLUMENSCHEIN, GR
    CARDENAS, JO
    LIVINGSTON, RB
    EINHORN, LH
    FREIREICH, EJ
    GOTTLIEB, JA
    CLINICAL RESEARCH, 1975, 23 (03): : A336 - A336
  • [44] ADJUVANT CHEMOTHERAPY COMBINED WITH TAMOXIFEN IN POSTMENOPAUSAL PATIENTS WITH STAGE-II BREAST-CANCER
    ZIELINSKI, CC
    KUBISTA, E
    SALZER, H
    SEVELDA, P
    LANGER, M
    STAFFEN, A
    SPONA, J
    AIGINGER, P
    LANCET, 1986, 2 (8516): : 1164 - 1164
  • [45] A PHASE-II TRIAL OF WEEKLY HIGH-DOSE FOLINIC ACID AND 5-FLUOROURACIL IN COMBINATION WITH EPIRUBICIN AS SALVAGE CHEMOTHERAPY IN ADVANCED BREAST-CANCER
    STOGER, H
    SCHMID, M
    BAUERNHOFER, T
    MOSER, R
    PLONER, F
    DERSTVENSCHEG, E
    KASPAREK, AK
    KUSS, I
    WILDERSTRUSCHNIG, M
    LACKNER, C
    STEINDORFER, P
    SAMONIGG, H
    ONCOLOGY, 1994, 51 (06) : 518 - 522
  • [46] ADJUVANT TAMOXIFEN THERAPY IN STAGE-II BREAST-CANCER
    MARSHALL, JS
    HUBAY, CA
    PEARSON, OH
    GORDON, N
    CROWE, J
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 167 - 167
  • [47] A RANDOMIZED TRIAL COMPARING 12 WEEKS WITH 36 WEEKS OF ADJUVANT CHEMOTHERAPY IN STAGE-II BREAST-CANCER
    LEVINE, M
    GENT, M
    HRYNIUK, W
    LEVIN, L
    ABUZAHRA, H
    ARNOLD, A
    SKILLINGS, J
    BRAMWELL, V
    DEPAUW, S
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 144 - 144
  • [48] A CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN VERSUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST-CANCER
    HOWELL, A
    RUBENS, RD
    BUSH, H
    GEORGE, WD
    HOWAT, JMT
    CROWTHER, D
    SELLWOOD, RA
    HAYWARD, JL
    KNIGHT, RK
    BULBROOK, RD
    FENTIMAN, IS
    CHAUDARY, M
    RECENT RESULTS IN CANCER RESEARCH, 1984, 96 : 74 - 89
  • [49] MITOXANTRONE, 5-FLUOROURACIL AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER
    MARTONI, A
    RANI, P
    ERCOLINO, L
    CANOVA, N
    PANNUTI, F
    CHEMIOTERAPIA, 1988, 7 (05): : 345 - 349
  • [50] COMPARISON OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 5-FLUOROURACIL VERSUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL IN METASTATIC BREAST-CANCER
    BULL, J
    TORMEY, D
    FALKSON, G
    BLOM, J
    PERLIN, E
    CARBONE, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 246 - 246
12345